ScoreWhy is IDEXX Laboratories, Inc. ?
1
High Management Efficiency with a high ROCE of 54.00%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.58 times
3
Healthy long term growth as Operating profit has grown by an annual rate 14.55%
4
With a growth in Net Profit of 15.11%, the company declared Very Positive results in Jun 26
- The company has declared positive results for the last 2 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 1,367.77 MM
- ROCE(HY) Highest at 74.21%
- INVENTORY TURNOVER RATIO(HY) Highest at 4.35 times
5
With ROCE of 59.38%, it has a fair valuation with a 24.95 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -19.03%, its profits have risen by 19.3% ; the PEG ratio of the company is 2.4
6
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 3.49% over the previous quarter.
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to IDEXX Laboratories, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is IDEXX Laboratories, Inc. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
IDEXX Laboratories, Inc.
-19.49%
0.08
32.44%
S&P 500
15.76%
1.22
13.15%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
9.72%
EBIT Growth (5y)
14.55%
EBIT to Interest (avg)
26.58
Debt to EBITDA (avg)
0.75
Net Debt to Equity (avg)
0.55
Sales to Capital Employed (avg)
1.56
Tax Ratio
20.41%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
96.51%
ROCE (avg)
54.00%
ROE (avg)
82.05%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
54
Industry P/E
Price to Book Value
35.32
EV to EBIT
42.02
EV to EBITDA
37.98
EV to Capital Employed
24.95
EV to Sales
13.34
PEG Ratio
2.41
Dividend Yield
NA
ROCE (Latest)
59.38%
ROE (Latest)
65.86%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 1,367.77 MM
ROCE(HY)
Highest at 74.21%
INVENTORY TURNOVER RATIO(HY)
Highest at 4.35 times
RAW MATERIAL COST(Y)
Fallen by -2.54% (YoY
NET SALES(Q)
Highest at USD 1,216.59 MM
OPERATING PROFIT(Q)
Highest at USD 467.05 MM
OPERATING PROFIT MARGIN(Q)
Highest at 38.39 %
PRE-TAX PROFIT(Q)
Highest at USD 414.89 MM
NET PROFIT(Q)
Highest at USD 336.52 MM
EPS(Q)
Highest at USD 4.27
-2What is not working for the Company
INTEREST(Q)
At USD 11.46 MM has Grown at 28.15%
Here's what is working for IDEXX Laboratories, Inc.
Inventory Turnover Ratio
Highest at 4.35 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Operating Cash Flow
Highest at USD 1,367.77 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 1,216.59 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 467.05 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 38.39 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD 414.89 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 336.52 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 4.27
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Raw Material Cost
Fallen by -2.54% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 41.05 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for IDEXX Laboratories, Inc.
Interest
At USD 11.46 MM has Grown at 28.15%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Footer loading
